PARLIAMENTARY WRITTEN QUESTION
(15 November 2024)

To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the potential impact of the Royal Marsden Man Van project on prostate cancer testing in areas with high rates of late diagnosis.

Asked by:
Josh Babarinde (Liberal Democrat)

NHS England has not made a specific assessment.

We will find the safest and most effective way to screen for prostate cancer. The Department is investing £16 million into the Prostate Cancer UK led Transform screening trial, which seeks to diagnose prostate cancer as early as possible. This trial will compare the most promising tests that look for prostate cancer in men that do not have symptoms, and aims to address disparities in early detection rates across different groups.

NHS England has funded 10 clinical audits, which includes audit work on prostate cancer. Using routine data, collected on patients diagnosed with cancer in a National Health Service setting, the audit will look at what is being done well, where it’s being done well, and what needs to be done better. This will seek to reduce unwarranted variation in treatment and reduce inequalities across different groups.

Answered by:
()